NCT00321620 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 951
- group Id
- BG001
- value
- 950
- group Id
- BG002
- value
- 1901
- units
- Participants
- groups
- description
- Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks
- id
- BG000
- title
- Zoledronic Acid
- description
- Denosumab 120 mg subcutaneously with an intravenous zoledronic acid placebo once every 4 weeks
- id
- BG001
- title
- Denosumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.4
- value
- 71.0
- group Id
- BG001
- spread
- 8.7
- value
- 70.5
- group Id
- BG002
- spread
- 8.6
- value
- 70.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 951
- group Id
- BG001
- value
- 950
- group Id
- BG002
- value
- 1901
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 810
- group Id
- BG001
- value
- 829
- group Id
- BG002
- value
- 1639
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 73
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 102
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 48
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 37
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 145
- group Id
- BG001
- value
- 145
- group Id
- BG002
- value
- 290
- title
- PSA level < 10 ng/mL
- categories
- measurements
- group Id
- BG000
- value
- 806
- group Id
- BG001
- value
- 805
- group Id
- BG002
- value
- 1611
- title
- PSA level ≥ 10 ng/mL
- param Type
- NUMBER
- title
- Prostate-Specific Antigen (PSA) Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 231
- group Id
- BG001
- value
- 232
- group Id
- BG002
- value
- 463
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 720
- group Id
- BG001
- value
- 718
- group Id
- BG002
- value
- 1438
- title
- No
- param Type
- NUMBER
- title
- Previous Skeletal-Related Event (SRE) Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 132
- group Id
- BG002
- value
- 264
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 819
- group Id
- BG001
- value
- 818
- group Id
- BG002
- value
- 1637
- title
- No
- description
- Defined as within 6 weeks before randomization
- param Type
- NUMBER
- title
- Current Prostate Cancer Chemotherapy Stratification Factor
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 951
- group Id
- BG001
- value
- 950
- group Id
- BG002
- value
- 1901
- units
- Participants
- groups
- description
- Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks
- id
- BG000
- title
- Zoledronic Acid
- description
- Denosumab 120 mg subcutaneously with an intravenous zoledronic acid placebo once every 4 weeks
- id
- BG001
- title
- Denosumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.4
- value
- 71.0
- group Id
- BG001
- spread
- 8.7
- value
- 70.5
- group Id
- BG002
- spread
- 8.6
- value
- 70.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 951
- group Id
- BG001
- value
- 950
- group Id
- BG002
- value
- 1901
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 810
- group Id
- BG001
- value
- 829
- group Id
- BG002
- value
- 1639
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 73
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 102
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 48
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 37
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 145
- group Id
- BG001
- value
- 145
- group Id
- BG002
- value
- 290
- title
- PSA level < 10 ng/mL
- categories
- measurements
- group Id
- BG000
- value
- 806
- group Id
- BG001
- value
- 805
- group Id
- BG002
- value
- 1611
- title
- PSA level ≥ 10 ng/mL
- param Type
- NUMBER
- title
- Prostate-Specific Antigen (PSA) Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 231
- group Id
- BG001
- value
- 232
- group Id
- BG002
- value
- 463
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 720
- group Id
- BG001
- value
- 718
- group Id
- BG002
- value
- 1438
- title
- No
- param Type
- NUMBER
- title
- Previous Skeletal-Related Event (SRE) Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 132
- group Id
- BG002
- value
- 264
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 819
- group Id
- BG001
- value
- 818
- group Id
- BG002
- value
- 1637
- title
- No
- description
- Defined as within 6 weeks before randomization
- param Type
- NUMBER
- title
- Current Prostate Cancer Chemotherapy Stratification Factor
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle